Literature DB >> 24750052

Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.

Sarah E Lutz1, Justin Lengfeld, Dritan Agalliu.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24750052      PMCID： PMC4832963          DOI： 10.2217/rme.14.1

Source DB:  PubMed          Journal:  Regen Med        ISSN： 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  16 in total

1.  Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis.

Authors:  Jonnie Plumb; Stephen McQuaid; Meenakshi Mirakhur; John Kirk
Journal:  Brain Pathol       Date:  2002-04       Impact factor: 6.508

2.  Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration.

Authors:  Kenneth King Yin Liu; Katerina Dorovini-Zis
Journal:  J Neuroimmunol       Date:  2009-09-18       Impact factor: 3.478

3.  Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.

Authors:  Shibani Pati; Aarif Y Khakoo; Jing Zhao; Fernando Jimenez; Michael H Gerber; Matthew Harting; John B Redell; Raymond Grill; Yoichi Matsuo; Sushovan Guha; Charles S Cox; Marvin S Reitz; John B Holcomb; Pramod K Dash
Journal:  Stem Cells Dev       Date:  2010-10-18       Impact factor: 3.272

4.  Intracerebroventricular transplantation of ex vivo expanded endothelial colony-forming cells restores blood-brain barrier integrity and promotes angiogenesis of mice with traumatic brain injury.

Authors:  Xin-Tao Huang; Yong-Qiang Zhang; Sheng-Jie Li; Sheng-Hui Li; Qing Tang; Zhi-Tao Wang; Jing-Fei Dong; Jian-Ning Zhang
Journal:  J Neurotrauma       Date:  2013-11-21       Impact factor: 5.269

5.  Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway.

Authors:  Jaime Imitola; Khadir Raddassi; Kook In Park; Franz-Josef Mueller; Marta Nieto; Yang D Teng; Dan Frenkel; Jianxue Li; Richard L Sidman; Christopher A Walsh; Evan Y Snyder; Samia J Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

6.  An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.

Authors:  Moutih Rafei; Yamina A Berchiche; Elena Birman; Marie-Noëlle Boivin; Yoon Kow Young; Jian Hui Wu; Nikolaus Heveker; Jacques Galipeau
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

7.  Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.

Authors:  Lianhua Bai; Jordan Hecker; Amber Kerstetter; Robert H Miller
Journal:  Neurosci Bull       Date:  2013-03-08       Impact factor: 5.203

8.  Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.

Authors:  Peter J Darlington; Tarik Touil; Jean-Sebastien Doucet; Denis Gaucher; Joumana Zeidan; Dominique Gauchat; Rachel Corsini; Ho Jin Kim; Martin Duddy; Farzaneh Jalili; Nathalie Arbour; Hania Kebir; Jacqueline Chen; Douglas L Arnold; Marjorie Bowman; Jack Antel; Alexandre Prat; Mark S Freedman; Harold Atkins; Rafick Sekaly; Remi Cheynier; Amit Bar-Or
Journal:  Ann Neurol       Date:  2013-03-05       Impact factor: 10.422

9.  Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury.

Authors:  Tyler Menge; Yuhai Zhao; Jing Zhao; Kathryn Wataha; Michael Gerber; Jianhu Zhang; Phillip Letourneau; John Redell; Li Shen; Jing Wang; Zhalong Peng; Hasen Xue; Rosemary Kozar; Charles S Cox; Aarif Y Khakoo; John B Holcomb; Pramod K Dash; Shibani Pati
Journal:  Sci Transl Med       Date:  2012-11-21       Impact factor: 17.956

10.  Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.

Authors:  Lianhua Bai; Donald P Lennon; Arnold I Caplan; Anne DeChant; Jordan Hecker; Janet Kranso; Anita Zaremba; Robert H Miller
Journal:  Nat Neurosci       Date:  2012-06       Impact factor: 24.884
View more
  1 in total

Review 1.  Induced Stem Cells as a Novel Multiple Sclerosis Therapy.

Authors:  Chong Xie; Yan-Qun Liu; Yang-Tai Guan; Guang-Xian Zhang
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.